Migdal Insurance & Financial Holdings’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,656
Closed -$880K 743
2020
Q3
$880K Sell
6,656
-5,767
-46% -$753K 0.01% 309
2020
Q2
$1.44M Buy
12,423
+4,053
+48% +$467K 0.02% 219
2020
Q1
$821K Sell
8,370
-888
-10% -$116K 0.02% 201
2019
Q4
$1.34M Buy
9,258
+1,285
+16% +$177K 0.03% 183
2019
Q3
$1.06M Buy
7,973
+2,385
+43% +$308K 0.02% 239
2019
Q2
$639K Buy
5,588
+1,620
+41% +$190K 0.02% 296
2019
Q1
$492K Buy
3,968
+1,247
+46% +$142K 0.01% 306
2018
Q4
$274K Buy
2,721
+360
+15% +$40.5K 0.01% 324
2018
Q3
$301K Buy
2,361
+1,324
+128% +$157K 0.01% 473
2018
Q2
$112K Buy
1,037
+1,017
+5,085% +$111K ﹤0.01% 506
2018
Q1
$2K Buy
+20
New +$2.32K ﹤0.01% 620
2017
Q3
Sell
-618
Closed -$77K 588
2017
Q2
$77K Hold
618
﹤0.01% 369
2017
Q1
$73K Hold
618
﹤0.01% 378
2016
Q4
$62K Buy
+618
New +$66.2K ﹤0.01% 336

Other funds holding ZBH

Migdal Insurance & Financial Holdings's ZBH Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 6,656 shares — an estimated $880K sold.

Migdal Insurance & Financial Holdings first reported a position in ZBH in Q4 2016 and held it in 14 quarters. The position peaked at $1.44M in Q2 2020. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Migdal Insurance & Financial Holdings reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 6,656 Zimmer Biomet shares in Q4 2020, an estimated $880K.
  • Migdal Insurance & Financial Holdings first reported a position in Zimmer Biomet in Q4 2016 and held it in 14 quarters.
  • Migdal Insurance & Financial Holdings's Zimmer Biomet position peaked at $1.44M in Q2 2020.
  • 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.